Results Of Phase IIb Clinical Trial Of Short Ragweed Sublingual-Oral Immunotherapy At American Academy Of Allergy Asthma And Immunology Annual Meeting

Greer, a leading developer and provider of allergy immunotherapy products, today announced the results of its Phase IIb double-blind placebo-controlled dose response trial for the sublingual-oral immunotherapy (SLIT) administration of its standardized short ragweed pollen extract.

Joint Statement On FDA Investigation Of Singulair From The AAAAI And ACAAI

Leadership from the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma & Immunology released the following statement in response to the Thursday announcement of a Food and Drug Administration investigation into Singulair:There are no data from well-designed studies to indicate a link between Singulair and suicide.

Cedars-Sinai Pulmonologist Offers Commonsense Advice On Coping With A Prolific Allergy Season In California

California's generous winter rains have set the stage for a spectacularly lush spring-and a potentially severe allergy season, says Zab Mosenifar, M.D., medical director, Women's Guild Lung Institute at Cedars-Sinai Medical Center. "The trails are magnificent, " notes the longtime mountain runner, who just completed his 26th Catalina Marathon.

Troublesome Allergens Thrive In Humid Weather

About 40 million Americans suffer from "hay fever, " a disease that allergists prefer to call "allergic rhinitis, " because HAY is not to blame and FEVER is rarely a symptom.

Auriga Laboratories Announces The Launch Of Extendryl R PEM And Extendryl R GCP

Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the launch of Extendryl PEM and Extendryl GCP. The two new products will be marketed under the Extendryl brand name which consists of prescription products to treat various cough, cold, and allergy symptoms.

Dr. Hugh A. Sampson Elected President Of The American Academy Of Allergy, Asthma Immunology AAAAI

Hugh A. Sampson, MD, FAAAAI, was elected President of the American Academy of Allergy, Asthma & Immunology (AAAAI) during its 2008 Annual Meeting in Philadelphia. He will serve as President through March 2009. The AAAAI is the largest professional medical specialty organization in the United States representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic disease.